Abbreviated 8-week chemotherapy (CT) plus involved node radiotherapy (INRT) for nonbulky stage I-II Hodgkin lymphoma: Preliminary results of the Stanford G5 Study

Authors :: Steven A. Rosenberg
Sandra J. Horning
Richard T. Hoppe
Jeff Allen
Sarah E. Daadi
R. Advani
E. Jonathan
Source :: Journal of Clinical Oncology. 29:8064-8064
Publication Year :: 2011
Publisher :: American Society of Clinical Oncology (ASCO), 2011.
Abstract: 8064 Background: Combined modality therapy is the standard of care for non-bulky Stage I-II HL. Currently, brief CT +30 Gy involved field (IF) radiotherapy (RT) is associated with a high cure rate....

Subjects :: Cancer Research
Chemotherapy
Standard of care
business.industry
medicine.medical_treatment
Involved node radiotherapy
Stage i ii
Radiation therapy
Oncology
medicine
Combined Modality Therapy
Hodgkin lymphoma
Stage (cooking)
Nuclear medicine
business

Full Text Access

Tools